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Abstract
The older Finnish Twin Cohort (FTC) was established in 1974. The baseline survey was in 1975, with two follow-up health surveys in 1981 and
1990. The fourth wave of assessments was done in three parts, with a questionnaire study of twins born during 1945–1957 in 2011–2012, while
older twins were interviewed and screened for dementia in two time periods, between 1999 and 2007 for twins born before 1938 and between
2013 and 2017 for twins born in 1938–1944. The content of these wave 4 assessments is described and some initial results are described. In
addition, we have invited twin-pairs, based on response to the cohortwide surveys, to participate in detailed in-person studies; these are
described briefly together with key results. We also review other projects based on the older FTC and provide information on the biobanking
of biosamples and related phenotypes.
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The older Finnish Twin Cohort (FTC) was established 45 years ago
and has been described extensively in prior reviews (Kaprio, 2006,
2013; Kaprio & Koskenvuo, 2002). Here, we will review the con-
tinued follow-up of the cohort, describe important legislative
changes that affect how the cohort can and will be available to
researchers and describe in more detail some of the more extensive
research projects based partially or entirely on the adult cohort.
Since its establishment, the FTC has been hosted by the
University of Helsinki and the primary goal in the 1970s and early
1980s was to study twin-pairs discordant for smoking, as the causal
evidence for smoking inmajor diseases was still lacking. During the
1980s, quantitative genetic modeling became more common in
published papers based on the cohort, primarily through collabo-
rations with Indiana University and Professor Richard J. Rose. In
the 1990s, as a result of collaboration with the National Public
Health Institute of Finland and Professors Leena Peltonen and
Jussi Huttunen, DNA samples were collected with the aim of
addressing the genetic architecture of complex traits and diseases
such as hypertension, obesity, migraine, diabetes and osteoarthri-
tis, to mention a few of the first projects. We also expanded collab-
orations with other research groups in Finland, permitting much
more detailed phenotyping and analyses in selected subsets of
twins, some of which are described later. International collabora-
tions have allowed for fruitful exchange of ideas, pooling of results
and training of young scientists in multicenter studies.
Data Collections
Questionnaire and Interview Studies
Earlier questionnaires were mailed in 1975 and 1981 to all twins
born before 1958 and living in Finland, identified from the popu-
lation register of Finland; the 1990 third-wave questionnaire was
targeted to twins born in 1930–1957 who had responded to either
earlier questionnaire. Numbers and details are shown in the first
three rows of Table 1.
The fourth wave of cohortwide data collection has been con-
ducted in three separate phases and with separate data collection
methods.We invited the participation of twins based on their birth
years (those born before 1938, 1938–1944 and 1945–1957) for
studies conducted between 1999 and 2017. In addition, selected
subsets of twins have been approached for more intensive clinical
studies.
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Cognitive Screening Studies
Starting in 1999, twins from the FTC over 65 years old, and even-
tually including all those born before 1938, were invited to partici-
pate in a telephone interview assessing cognitive functioning. Two
validated instruments were used: a telephone assessment of
dementia (TELE; Gatz et al., 2002) and Telephone Interview for
Cognitive Status (TICS; Brandt et al., 1988). Also, a 1-min category
(animals) fluency task was administered. The first part of the data
collection took place in 1999–2007 and included twins born before
1938. More specifically, monozygotic (MZ) twin-pairs (both mem-
bers of a pair alive) were interviewed in 1999–2001 and dizygotic
(DZ) twins and those with uncertain zygosity, irrespective of the
co-twin’s vital status, were interviewed in 2003–2007. All partici-
pants were also asked to provide a blood sample for extracting
DNA. There were a total of 2606 twins who participated in the tele-
phone interview at a mean age of 74 years. The study collection is
termed MEMTWIN I in Table 1.
The second part of the data collection was performed in 2013–
2017 and included cohorts born in 1938–1944 (MEMTWIN II in
Table 1). All twins — regardless of co-twin’s vital status — were
asked to participate. Cognitive measures were similar to earlier
data collection, with the exception of using the modified version
of the TICS (TICS-m, including a delayed free recall of 10-word
list). In addition to cognitive instruments, the Center for
Epidemiological Studies Depression scale (CES-D) was also
included (Radloff, 1977). All individuals were also asked to partici-
pate in a saliva sample collection for extraction of DNA. A total of
1813 twins participated in the telephone interview at a mean age of
74 years. Twins born in 1940–1944 were invited to take part in
objective measures of physical activity. See below for details and
first results.
These two data collections, collectively calledMEMTWIN, have
cognitive data available from a total of 4429 twins with a partici-
pation rate of 67% (Lindgren et al., 2019). Of these, 3614 have
genotype data. Informed consent was obtained from participants,
and the study protocol was approved by the Ethics Committee of
the Hospital District of Southwest Finland. We are currently plan-
ning to administer postal questionnaires and telephone interviews
for all FTC twins who reach 90 years of age. Selected pairs
potentially discordant for cognitive impairment were invited to
the national PET Centre, University of Turku for neuropsychologi-
cal (NP) assessments, magnetic resonance imaging (MRI) and
positron emission tomography (PET) imaging.
Lifestyle, Health and Behavioral Changes Over 35 Years
In the 2013 review (Kaprio, 2013), the mailed survey conducted
among twins born in 1945–1957 was described in detail. In brief,
the questionnaire had 85 questions (and 240 items). The topics
covered items about contact with their co-twin, health and risk fac-
tors (blood pressure [BP] and cholesterol measurements, diabetes,
breathlessness, back pain, bruxism, chronic diseases and use of
common medications). Women were asked about hormone
replacement therapy (HRT) use. Six questions on sleep were
included. Eight items on work and pension intentions were asked
next. Twelve questions asked a detailed smoking history, including
two nicotine dependence scales, while seven questions were
directed to alcohol quantity, frequency and problem drinking.
Six items asked about leisure-time physical activity (LTPA) and
sedentary behavior. Life events and traumatic experiences in child-
hood and adulthood were questioned, as well as items on social
interactions. We repeated the four-item life satisfaction scale,
and the brief assessment of extraversion and neuroticism (19 items
together) asked in previous surveys. We included the CES-D
depression scale. Finally, we asked about their current height
and weight, as well as weight from 1 year and 5 years earlier, as
well as their weight at age 50 and largest weight ever. Finally,
the participants were asked to self-measure their waist circumfer-
ence with a tape measure included with the questionnaire. We
found that this had acceptably high validity when measured by
health professionals in the Epigenetics of Hypertension study
(Tuomela et al., in press). This has enabled longitudinal analyses
spanning up to four measurements and 35 years of follow-up
(see below for more detail on analyses related to alcohol, weight
and physical inactivity). The details of the three subsets of wave
4 are also shown in Table 1, while Figure 1 gives the numbers of
twins who have answered various combinations of surveys, which
helps when planning longitudinal analyses.
Table 1. Questionnaires and interviews of the adult twin cohort in four waves of data collection. The fourth wave was spread over two decades and used either
interviews or questionnaires for data collection in three separate substudies defined by birth year
















Wave 1 Q 1975 –1957 36,922a 31,145a 36 (14.7), 18–95 16,010 15,135 3639 7721
Wave 2 Q 1981 –1957 29,311 24,684 41.1 (13.8),
24–101
12,755 11,929 3132 6483
Wave 3 Q 1990 1930–1957 16,179 12,502 44.4 (7.8), 33–61 6804 5698 1607 3079
Wave 4
(MEMTWIN I)
I 1999–2007 Before 1938 3579 2606 74.4 (5.3), 57–97 1251 1355 342 506
Wave 4
(MEMTWIN II)
I 2013–2017 1938–1944 2998 1813 73.8 (1.6), 61–78 900 913 220 333
Wave 4 Q 2011–2012 1945–1957 11,738 8410 60.3 (3.8), 53–68 4657 3753 1070 1862
Note: I= Interview, Q= Questionnaires
aAt wave 1, these numbers include nonbiological twins who satisfied the original selection criteria (pairs of persons with the same surname at birth, same birth date, same local community of
birth and same sex) in 1974.
Twin Research and Human Genetics 241
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
Fig. 1. Overlap in responses to waves 1–4 studies for the FTC. Panel A: The entire cohort; Panel B: twins born before 1938 and assessed for cognition in wave 4 (older
part of MEMTWIN); Panel C: twins born 1938–1944 and assessed for cognition in wave 4 (young part of MEMTWIN) and Panel D: twins born in 1945–1957.
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Epigenetics of Hypertension Study
Based on the 2011 survey, a few years later, we undertook an
in-person study on the epigenetics of hypertension (EH-Epi study,
see below) as part of a consortium project led by Dr XiaolingWang
(Georgia Prevention Institute, Augusta University, GA, USA). A
total of 447 twins were examined and measured, including four
measurements of BP at two separate time points, weight, height
as well as waist and hip circumferences, as well as fasting glucose
and cell counts (60 items). A lifestyle interview had items on cur-
rent medications, use of alcohol, smoking, occupation, physical
Fig. 1. (continued)
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activity at leisure and handedness (160 items). The participants
also completed a 56-item brief food frequency questionnaire.
Blood samples were taken for genetic and epigenetic studies
(DNA methylation using 450-k arrays, next-generation sequencing
for miRNA and histonemodification analyses), as well as for metab-
olomics on several platforms and transcriptomics. See below for
more details and initial results.
Inheritance of Drinking Behavior Cohort
While the older FTC is large and comprehensive, it is not the first
in Finland. There is a well-known study of male twins born in the
1920s who took part in a study of genetics of alcohol use and abuse,
summarized in the book Inheritance of Drinking Behavior, by Juha
Partanen, Kettil Bruun and Touko Markkanen (Partanen et al.,
1966). They studied in detail 902 male twin-pairs aged 28–37 years
in 1958, and we have now been able to access this interview data.
We are currently re-entering the paper interviews as the previous
electronic records no longer exist. The interviewwas extensive with
182 items on biographical data, relationships between co-twins,
external circumstances, drinking behavior, illnesses, food and taste
preferences and anthropological measures. In addition, intelli-
gence and personality tests were conducted and blood samples
drawn. As many of the pairs have also taken part in our 1975
and 1981 surveys, this dataset will add data from one more data
point to the longitudinal study.
Register Linkages
Through regular register linkages, we have updated vital status and
address information as needed, while cancer incidence and cause of
death data are updated from the Cancer Registry and Statistics
Finland, respectively. For more details on ongoing cancer research,
see the review on the Nordic Twin Study of Cancer (Mucci et al.,
2016). In addition, some analyses of predictors of cancer incidence
have been done on the Finnish data alone. More extensive register
linkages have been waiting for new legislation on accessing health
and social data. The number of deaths and number of cancer cases
(all kinds of malignancies) are shown in Table 2 for the like-sex
twins who have replied to the specified surveys. This enables plan-
ning of analyses of exposure data collected at the surveys in relation
to cause of death or cancer outcomes.
The Finnish Parliament has also approved the Act on the
Secondary Use of Health and Social Data in 2019. It enables wider
and speedier use of the data not only from national social and
health care registers but also from the operational client and
patient systems in primary care, specialist health care and social
services. Decisions on accessing the data will be taken by the
newData Permit Authority as a centralized national actor. For sen-
sitive data, it will be required to be handled in a safe and secure
environment, such that only the results of the analytics can be used
externally. Potentially, this will permit linkage of the twin cohort to
multiple new registers for novel analyses. The new regulation
implements the GDPR (the EU’s General Data Protection
Regulation) in Finland. It is one of the first implementations of
the GDPR for the secondary use of data in Europe.
Biobanking
As part of the Finnish Biobanking Legislation (law 688/2012), all
biological samples associated with the FinnTwin12 study, the
FinnTwin16 study and the older FTC have been deposited in
2018 with the nationwide Biobank of the National Institute for
Health and Welfare, which has a license to operate from the
National Supervisory Authority for Welfare and Health.
Biobanked data are publicly available for use by qualified research-
ers worldwide following a standardized application procedure.
Access to coded data is managed and controlled by the Biobank
in accordance with the limitations of the consent forms signed
by participants and Finnish law. A unique feature of the
Biobank is the ability to link study records to Finland’s national
health and social welfare registries, which includes extensive infor-
mation regarding medical diagnoses and receipt of social services
(e.g., disability claims). For details on accessing the biobanked data
on the twins, see https://thl.fi/en/web/thl-biobank/for-researchers/
application-process.
There are also hospital-based biobanks in Finland, where the
pathology archives from the past 30 years or more are accessible.
We are in the process of linking the older FTC to pathology
archives to identify tissue samples from twin-pairs in which one
or both twins have selected cancers, such as prostate, breast, colo-
rectal and lung cancer. This has now become easier as there is a
single portal, called FINGENIOUS, run by the Finnish Biobank
cooperative (https://finbb.fi/), by which one can reach all six
Finnish hospital biobanks by completing just one feasibility and
access request.
ManyDNA samples have been collected during targeted studies
of selected pairs, conducted from the early 1990s onward, and all
available samples have now been genotyped, imputed and available
for genomewide association studies (GWASs) and other analyses.
Table 2 also gives numbers of persons with genomewide genotypes
Table 2. Number of deaths, cancer cases in the twin cohort by survey year and the numbers genotyped or with methylation data. The number of pairs genotyped on a
genomewide array












N of MZ pairs with at
least one twin
genotyped
N of DZ pairs with
both twins
genotyped
Wave 1 Q 1975 –1957 12,652 5477 8579 430 1427 2203
Wave 2 Q 1981 –1957 9221 5030 8404 420 1404 2123
Wave 3 Q 1990 1930–1957 2530 2309 6125 349 961 1455
Wave 4
(MEMTWIN I)
I 1999–2007 Before 1938 1413 839 1952 10 156 437
Wave 4
(MEMTWIN II)
I 2003–2016 1938–1944 81 334 1662 2 218 306
Wave 4 Q 2011–2012 1945–1957 375 975 2743 423 541 600
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or methylation data. Please note that the methylation data have
generally been collected in later years, and not necessarily at the
same time as the latest surveys but rather at the time of the respec-
tive substudy during an on-site visit. We also have some informa-
tion on opposite-sex twins, some of which is register-based (twins
born in 1950–1957) and some through questionnaire contact in
1996–1997 for twins born in the 1940s. Across all three cohorts,
we have DNA samples on more than 15,000 twins and family
members, who have taken part in family studies. Notably, the
opposite-sex twins and first-degree relatives in the Nicotine
Addiction Genetics (NAG) family study are not tabled here.
Almost 2000 methylation arrays have been done overall with
526 in the old cohort from 442 individuals and 83 with repeated
measures. We are currently undertaking more methylation array
analyses, which will add some 400 more in the old FTC. The more
detailed breakdown of Ns will be given in separate review papers
for Finntwin12 and Finntwin16 in the forthcoming special issue of
twin registries in this journal. In addition, there are transcriptomics,
histone modifications, miRNA analyses and metabolomics in
selected subsets of twins.
Main Scientific Projects in Recent Years
In the following sections, the major recent and ongoing scientific
projects undertaken based on the FTC are described. The list of
projects is not comprehensive, and projects initiated more than
10 years ago that have been completed are not included.
Moreover, our contributions of many GWASs and Mendelian
randomization summary statistics to multiple consortia exploring
the genetics of common, complex traits and conditions are not
described in detail.
Hypertension Epigenetics
Both genetic and environmental factors contribute to the pathogen-
esis of essential hypertension (EH). The GWASs have shown that the
associated single-nucleotide polymorphisms (SNPs) explain less than
6% of the BP variation in the population (Evangelou et al., 2018;
Hoffmann et al., 2017; Wain et al., 2017; Warren et al., 2017).
Emerging evidence suggests that epigenetic variants play an impor-
tant role in the pathogenesis of EH (Kato et al., 2015; Wang et al.,
2013). Altogether, 199 twin-pairs and four singletons (age 55–69
years; 60.7% monozygous) from the EH-Epi substudy were included
in epigenome and transcriptomewide analysis of hypertension. We
identified 13 novel CpG methylation sites (article in preparation)
and one new gene, MOK with its expression associated with BP,
and replicated several previously identified signals in both gene
expression and DNA methylation level. Results from bivariate twin
modeling further provided new insights into the genetic and environ-
mental sources of BP-related DNAmethylation and gene expression
signatures (Huang et al., 2018).
Smoking and Mental Health Disorders
Depression and smoking are strongly associated, but the causal
nature of their relationship is debated. Depression is a major risk
factor for suicide and suicidality, but the role of smoking in suicide is
unclear. We have examined longitudinal associations between smok-
ing, depression and suicidality using the data from the older FTC.
We studied smoking behavior in 1975–1981 as a predictor of
depression in 1990 (The Beck Depression Inventory, BDI score
> 9) among 4164 men and 4934 women. Among the men, persis-
tent smoking and smoking in 1975 but quitting by 1981 were
associated with a higher risk of depression, while among the
women only the quitters had an elevated risk. When family and
genetic background were controlled, smoking remained a predic-
tor of depression. Genetic modeling among men suggested a
modest correlation (rg= .25) between the genetic components of
smoking and depression (Korhonen et al., 2007).
We further examined which depression dimensions are linked
to smoking patterns (4980 men and 5997 women). Longitudinal
cigarette smoking patterns in 1975–1981 included multiple catego-
ries describing consistency and change. The three BDI dimensions
were negative attitudes toward self (NATS), performance impair-
ment and weight loss assessed in 1990. Persistent smoking and
inconsistent former smoking predicted all the depression dimen-
sions, although such associations with the NATS dimension were
independent among men only. Long-term abstinence (consistent
former smoking) did not predict risk for any depression dimension.
Controlling for familial confounding, the association of persistent
smokingwith later NATSwas replicatedwithin discordant twin-pairs,
suggesting that smoking is most robustly associated with the ‘core
dimension’ of depression, that is, NATS (Korhonen et al., 2011).
While these previous studies were based on self-reported
depressive symptoms, the last study investigated whether smoking
predicts register-based outcome, that is, antidepressant medication
(n= 10,652). A questionnaire was administered to Finnish adult
twins in 1990. Antidepressant prescription data during 1995–
2004 were obtained from the register of the Finnish Social
Insurance Institution and linked to the survey data. Cox
Proportional Hazard Models among 1075 cases and 9577 controls
assessed the risk for depression in the cohort, whereas within-pair
comparisons of smoking twins with their nonsmoking co-twins
controlled for shared familial influences. Based on the analysis
among those without baseline depression, heavy daily smokers
had a significantly elevated likelihood for antidepressant prescrip-
tion when adjusted for all confounders. A similar analysis using
pairs discordant for antidepressant medication confirmed that
daily smoking twins had a higher likelihood for antidepressant pre-
scriptions compared with their nonsmoking co-twins (Korhonen
et al., 2017).
Within the older FTC, we investigated the relationship between
smoking and suicide among 16,282 twin-pairs born before 1958.
Smoking status and dose, marital status, employment and socio-
economic status and indicators of psychiatric and somatic illness
were assessed at both 1975 and 1981 surveys. Emergent psychiatric
and medical illness and vital status, including suicide determined
by forensic autopsy, were evaluated over 35-year follow-up
through national registries. The association between smoking
and suicide was determined in competing risks hazard models.
In twin-pairs discordant for smoking and suicide, the prospective
association between smoking and suicide was determined using a
matched case-control design. Smokers had a higher cumulative
suicide incidence than former or never smokers. Heavy smokers
had significantly higher suicide risk than light smokers.
Compared with never smokers, smokers, but not former smokers,
had increased suicide risk, adjusting for depressive symptoms,
alcohol and sedative-hypnotic use, and excluding those who devel-
oped a serious somatic or psychiatric illness. In twin-pairs discord-
ant for smoking and suicide, suicide was more likely in smokers.
Adults who smoked tobacco were more likely to die by suicide,
with a large, dose-dependent effect. This effect remained after con-
sideration of many known predictors of suicide and shared familial
effects, consistent with the hypothesis that exposure to tobacco
smoke increases the risk of suicide (Evins et al., 2017).
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Sleep
Sleep is also a major determinant of wellbeing and mental health,
and over the past decades we have reported on the genetic and
environmental contributions to sleep length and quality, as well
as many other sleep-related traits, such as snoring, parasomnias
and sleep bruxism. Recently, we have examined longitudinal asso-
ciations of sleep quality across the four surveys among twins born
in 1945–1957, showing that the large majority of respondents sleep
well or very well across a 35-year period, while very few are
consistently poor sleepers, indicating that more or less short-term
circumstances, such as life events or illnesses, probably lie behind
episodes of poor sleep, and poor sleep is persistent only among very
few individuals (Hublin et al., 2018). A longitudinal analysis of
sleep length is ongoing.
Genetics and Epigenetics of Smoking, Nicotine Metabolism
and Nicotine Dependence
Smoking behavior is influenced by both genetic and environmental
factors, and epigenetic factors may link these two. FTC twins who
have participated in the NAG, Schizophrenia and EH-Epi studies
have been used to investigate both genetics and epigenetics and
their interaction in smoking-related traits. Data from the
FinnTwin12 and FinnTwin16 cohorts have also contributed.
Genetics has been assessed by SNPs, while epigenetics has been
assessed by measuring DNA methylation using genomewide array
technologies.
Using the FinnTwin12 and FinnTwin16 together with other
Finnish data (N= 1518), we performed the first GWAS on the rate
of nicotine metabolism (Loukola et al., 2015), which influences
smoking behavior such as response to smoking cessation treat-
ments (Lerman et al., 2006). We found an association locus on
chromosome 19, harboring theCYP2A6 gene. Based on our results,
we constructed a genetic risk score explaining ~30% of the variance
observed in the nicotine metabolite ratio (NMR) to study the asso-
ciation of the NMR and smoking in the older FTC data and other
Finnish data. The genetic risk score was positively associated with
cigarettes smoked per day (CPD) and smoking cessation, sug-
gesting that individuals with faster nicotine metabolism smoke
more, but are more likely to quit. The latter association was no
longer statistically significant after accounting for potential con-
founders, such as quitting due to adverse health consequences
or having major depression (Loukola et al., 2015).
Subsequently, we performed GWASmeta-analyses of the NMR
and five other smoking-related traits in 5185 Finnish, Canadian
and Australian current smokers, including data from the FTC
(Buchwald et al., 2019). This was the largest GWAS to date of
the NMR, and the first of the nicotine intake biomarker, cotinine
þ 3hydroxycotinine, and the smoking intensity variable, cotinine/
CPD.We replicated previous findings, such as the chromosome 19
association locus for the NMR, as well as revealed new association
loci and shed light on the genetic overlap between the studied traits.
We have also contributed to multiple other meta-analyses of
GWAS data on various smoking and alcohol phenotypes, notably
the GSCAN consortium GWAS and exome analyses (Brazel et al.,
2018; Erzurumluoglu et al., 2019; Liu et al., 2019), for nicotine
dependence (Hancock et al., 2018) and alcohol dependence
(Walters et al, 2018). These analyses have been based on alcohol
and smoking behavior data from the surveys, as well as from
the structured psychiatric interviews conducted as part of the
NAG study. Additionally, we used the FTC data in our targeted
hypothesis-driven study of the neuregulin signaling pathway
(Gupta et al., 2017). Our neuregulin signaling pathway-targeted
analyses resulted in identification of SNPs with regulatory poten-
tial and provide evidence for the involvement of the pathway in
smoking behavior and comorbid diseases. We have also done a
GWAS on detailed smoking phenotypes covering the time depend-
ency of progression of a smoker from initiation, to becoming a
regular smoker, to smoking cessation based on detailed phenotyp-
ing in the NAG study (He et al., 2016).
The epigenome has been screened by epigenomewide associa-
tion studies to identify genomic regions that are affected by or may
influence smoking behavior (Gupta et al., 2019). Genetic and epi-
genetic data have also been integrated to uncover the regulatory
potential of those variants that associate with smoking behavior
phenotypes. We have observed multiple cis and trans methylation
quantitative trait loci at genomewide significant SNPs or CpG sites
and showed that DNA methylation is a molecular mechanism
mediating the effects of genotype on smoking behavior phenotypes
at some genetic loci (Gupta et al., 2019; Loukola et al., 2015).
As is well known, self-reported smoking status is prone to mis-
classification due to under-reporting, while biomarkers such as
cotinine can measure only recent exposure. It is also known that
smoking strongly influences DNA methylation, with current, for-
mer and never smokers exhibiting different methylation profiles.
To meet the needs for accurate smoking status estimation, we have
developed a robust DNA methylation-based predictor,
EpiSmokEr, providing an objective measure of smoking status
(https://github.com/sailalithabollepalli/EpiSmokEr; Bollepalli et al.,
2019). DNA methylation profiles of 405 EH-Epi twins were used
in this project as a test dataset.
Alcohol Use and Its Consequences Over Time
Using measures of alcohol use behaviors at each study wave, we
investigated birth cohort effects on the quantity and heritability
of alcohol use. As expected, twins in earlier birth cohorts were
more often abstainers and consumed less alcohol. However, we
also found the contribution of genetic and environmental factors
to variation in alcohol consumption to vary by birth cohort: in ear-
lier cohorts, environmental factors shared by co-twins were more
important, whereas the heritability of alcohol use behaviors was
higher in more recent cohorts (Virtanen et al., 2018). The FTC
offers unusual opportunities to study long-term associations of
alcohol use and test for familial/genetic confounds in comparisons
to exposure discordant MZ twin-pairs. While earlier analyses of
alcohol use discordant pairs had not shown differences in mortal-
ity, longer follow-up and more refined phenotypes show that even
in MZ twin-pairs discordant for alcohol use, the heavier user has a
higher risk of death (Sipilä et al., 2015).
We have completed an interview study of twin-pairs discordant
for alcohol use in the 1975 baseline. From all pairs born in 1951–1957
in which both co-twins completed the 2011–2012 questionnaire fol-
low-up, 171 pairs, confirmed or assumed to be MZ, were selected for
their drinking discordance in 1975 when aged 18–25 years.
Questionnaire measures of drinking over the 37-year follow-up
confirm substantial stability for both individual differences and intra-
pair differences for consumption and alcohol problems across the
nearly four-decade follow-up. The signed differences in consumption
patterns on which pairs were selected in 1975 remained significant
(albeit attenuated in magnitude) in the 2011–2012 questionnaire.
Semistructured telephone interviews were completed for 128 of these
171 drinking-discordant twin-pairs, and intrapair differences in
symptom counts of alcohol use disorder significantly correlated with
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measures of psychological wellbeing, general health, self-esteem and
satisfaction with life. A smaller subset of interviewed pairs from the
FinnTwin16 study shows similar findings from earlier ages and over
a shorter duration of follow-up; a report of the combined results is in
preparation awaiting zygosity confirmation for some twin-pairs.
Leisure-Time Physical Activity, Weight Gain, Health and
Mortality— A Prospective Follow-up in Twins
We have continued the analyses on whether LTPA, adjusted for
genetic factors and childhood environment, protects against mor-
tality and different adverse health outcomes. All questionnaires
(1975, 1981, 1990 and 2011) included questions on physical activ-
ity, allowing for a total metabolic equivalent (MET) index calcula-
tion (volume) by multiplying general intensity and the average
duration and frequency of physical activity during leisure time.
Different Finnish registers were used to study mortality, type 2 dia-
betes and use of antidepressants (measured as number of pur-
chases). Follow-up telephone interview with detailed questions
on the continuation of LTPA, self-measured weight and waist
circumference and occurrence of chronic disease was carried out
in 2005 (mean age 58.5 years) for physical activity discordant
twin-pairs (n= 146 twin-pairs).
During follow-up (1976–2004), 1082 type 2 diabetes cases were
observed among 20,487 individuals. Among all individuals, partic-
ipants in MET quintiles (Q) III–V had significantly decreased risk
for type 2 diabetes compared with sedentary individuals (QI). The
pairwise analyses showed that the bodymass index (BMI)-adjusted
hazard ratio (HR) for the active (QII–V) compared with sedentary
(QI) co-twins at follow-up was decreased by about one-half (0.54)
(Waller, Kaprio et al., 2010). Physical activity volume over 15 years
(1975–1990) was used as the predictor of subsequent use of anti-
depressants for 1995–2004 among 642 physical activity discordant
twin-pairs (Waller et al., 2016). Altogether, 229 persons had used at
least one prescribed antidepressant during the study period. Active
co-twins had a 20% lower risk for using any quantity of anti-
depressants than their inactive co-twins; trends were similar for
DZ (20% decrease) and MZ pairs (22% decrease). The lowest odds
ratio (OR) (0.51, 0.26–0.98) was seen amongMZ pairs after adjust-
ing for BMI, smoking and drinking.
Among the 146 LTPA discordant pairs, 24 co-twins (16 inac-
tive and 8 active) had died between 1981 and 2004. The active co-
twins had a strongly reduced risk of all-cause mortality as social
class-adjusted HR was significantly reduced (HR = 0.39; Waller,
Kujala, Rantanen et al., 2010). This was not found among the
small number of MZ pairs. Mortality follow-up was extended
for a period of 1981–2013 when twin-pairs discordant for vigo-
rous LTPA were studied (discordance in both 1975 and 1981).
This dataset included 1074 activity discordant twin-pairs (of
which 231 were MZ pairs). Among 278 activity and death dis-
cordant pairs, 180 inactive and 98 active co-twins had died during
follow-up. The unadjusted pairwise HR for all pairs was signifi-
cantly reduced for all pairs (0.64) and for DZ pairs (0.58) but not
for MZ pairs (0.85; Karvinen et al., 2015). When this analysis
was repeated in the baseline-healthy subgroup, the HRs were fur-
ther attenuated for DZ pairs and for MZ pairs (Karvinen
et al., 2015).
On the other hand, an increased mortality by 41% was observed
among twins with persistent dyspnea (breathlessness) at baseline
(dyspnea in 1975 and 1981) compared with asymptomatic individ-
uals. The within-pair analyses of death discordant pairs showed a
similar and significant increase of 47% for all twin-pairs, with a
point estimate of 164% for healthy MZ pairs (Waller et al., 2014).
Among the 95 interviewed physical activity discordant twin-
pairs, the risk of type 2 diabetes or glucose intolerance
(OR= 0.09, p= .022) and incident elevated BP (OR= 0.46,
p= .039) was lower among the active co-twins. The active co-twins
were more satisfied with their life at follow-up (p= .047). In con-
trast, the active co-twins showed a tendency toward more sports-
related injuries (OR = 1.9, p= .051; Waller, Kujala, Kaprio et al.,
2010). Within the subgroup of 42 pairs discordant for LTPA over
30 years, mean weight gain from 1975 through 2005 was 5.4 kg less
(p= .003) and waist circumference 8.4 cm smaller (p< .001) at fol-
low-up among the active compared with inactive co-twins (Waller
et al., 2008).
A smaller subgroup of twins participated in an accelerometer-
measured physical activity study called MOBILETWIN, which is a
subset of theMEMTWIN younger twins, as it included all available
same-sex twin-pairs born in 1940–1944. Twins completed a
telephone interview and answered the questionnaire, and
altogether 787 individuals, 404 women (283 complete pairs; 119
MZ pairs, mean age 72.9 years) wore a hip triaxial accelerometer
for at least 4 days in 2014–2016.
High baseline mean MET (mean from 1975, 1981 and 1990)
index predicted higher amounts of objectively measured moder-
ate-to-vigorous physical activity (MVPA), with an increase
in regression model R2 of 6.9% after age- and sex-adjustment
(p < .001) at follow-up among individuals (Waller, Vähä-Ypyä,
Lindgren et al., 2018). Self-reported fitness at follow-up explained
moderately the variation in measured MVPA (age- and sex-
adjusted R2 20%). MZ pairs were more similar (r= .57) in objec-
tively measured MVPA at follow-up compared to DZ pairs
(r= .28) (Waller, Vähä-Ypyä, Törmäkangas et al., 2018). Using
mediation analysis, it was shown that shared genetic factors
account for a large share of the associations between midlife and
later physical activity variables (rG= .59; 95% CI [0.44, 0.79];
Waller, Vähä-Ypyä, Lindgren et al., 2018). In later years, low objec-
tively measured physical activity was associated with the occur-
rence of chronic diseases (Kujala et al., 2019).
Three sets of analyses have examined causes and consequences
of long-term LTPA (>1.5 MET-h/day) and inactivity (≤1.5 MET-
h/day) by comparing 35-year LTPA profiles among twins born in
1945–1957 who replied to all four surveys in 1975, 1981, 1990 and
2011. The associations of 15-year smoking profile, education
attainment by 1981 and 35-year BMI change with physical inactiv-
ity were studied (Piirtola et al., 2016; Piirtola, Kaprio, Silventoinen
et al., 2017; Piirtola, Kaprio, Waller et al., 2017). We found that
long-term persistent daily smoking increased the likelihood of
either remaining or becoming physically inactive, whereas quitting
smoking decreased this likelihood (Piirtola, Kaprio, Waller et al.,
2017). In analyzing long-term smoking discordant twin-pairs,
any kind of smoking history was associated with physical inactiv-
ity. Further confirmation came from the observation that smoking
at midlife also predicted less objective measured MVPA at follow-
up in pairwise analysis amongMZ twin-pairs (Waller, Vähä-Ypyä,
Törmäkangas et al., 2018). Regarding another major risk factor, we
found that higher education protected from physical inactivity
because each additional year of education was associated with
lower likelihood for inactivity both in the cross-sectional and
longitudinal analyses (Piirtola et al., 2016). These associations held
true also for within-pair analyses, indicating an independent rela-
tionship between education attainment and LTPA. Persistent
physical activity was protective against weight gain, also for
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within-pair analyses, though somewhat attenuated coefficients
indicating confounding of familiar factors (Piirtola, Kaprio,
Waller et al., 2017).
In summary, physical activity helps in maintaining overall
health by decreasing the rate of weight gain, lowering waist circum-
ference, reducing the risk for clinical type 2 diabetes and use of
antidepressants. However, genetic factors may play a bigger role
in explaining the associations between physical activity and mor-
tality, as some of the findings were clearer among the DZ than MZ
twin-pairs discordant for LTPA.
Causes and Consequences of Physical Activity: The
TWINACTIVE Study
Sixteen twin-pairs (of whom seven were MZ pairs) with a persis-
tent discordance in their LTPA levels were comprehensively iden-
tified from the FTC (Leskinen, Waller et al., 2009). The
discordance between the co-twins of the twin-pairs was initially
defined from baseline questionnaires (1975 and 1981). A follow-
up interview (from 1980 to 2005) was set to assess discordance
in LTPA thereafter. The activity level assessment was based on cal-
culation of the volume of activity, the MET index, from the self-
reported physical activity.
Among the 16 pairs, the same twin had higher activity MET
index than his or her co-twin throughout the follow-up period
up to year 2007 when we conducted the multidimensional
health-related measurements. The co-twins did not differ in other
lifestyle factors, such as smoking, alcohol or work-related physical
activity habits, either at baseline assessment (1975) or at the end of
the follow-up (2007). The mean intrapair difference in LTPAMET
indexes between the co-twins for the follow-up period was exten-
sive, 8.8 MET h/day. As a result, the physically active co-twins had
higher peak exercise capacity (9.3 METs vs. 7.5 METs, p < .001)
and 20% higher knee extensor force compared to their inactive
co-twins (Leskinen et al., 2009, 2013).
At the end of the follow-up, the inactive twins had a higher
overall body fat content, 1.5 times more visceral and extramyocel-
lular thigh fat and a significantly higher liver fat score compared to
their active co-twins (Leskinen, Sipilä et al., 2009). These
differences were also seen among the MZ co-twins only
(Leskinen & Kujala, 2015). In skeletal muscle tissue, gene expres-
sion of the central pathways of energy metabolism and supportive
metabolic pathways, especially those genes related to the processes
of oxidative phosphorylation and branched-chain amino acid
(BCAA) degradation, were upregulated among the physically
active compared to inactive co-twins (Leskinen et al., 2010). In sub-
cutaneous fat tissue samples, the upregulated pathways in active
compared to inactive co-twins included BCAA degradation and
polyunsaturated fatty acid synthesis.
TWINACTIVE study shows that physically active lifestyle
maintains aerobic capacity and muscle strength. Regular physical
activity versus inactivity lowers the rate of ectopic fat accumulation
even when the genetic background is considered. These findings,
among our metabolomics finding (Kujala et al., 2013), indicate
lower cardio-metabolic risk among persistently active versus inac-
tive twins.
Predictors and Early Detection of Old Age Cognitive
Impairment and Dementia — The MEMTWIN and ADTWIN
Studies
Genetically informed studies of dementia risk factors with assess-
ment of future cognition or dementia are rare; for that reason, the
twin studies in our older twins were initiated as described above.
On the one hand, questionnaire and register-based information
were used (the MEMTWIN study); on the other hand, detailed
assessments among selected pairs using neuropsychology and neu-
roimaging were done (ADTWIN study).
MEMTWIN. Using the whole MEMTWIN data, Paula Iso-Markku
(Iso-Markku et al., 2015, 2016, 2018) has built on earlier work by
Jyri Virta et al. (2013) to look at physical activity and cognition in
particular. Although cross-sectional and longitudinal studies point
to an association of physical activity with reduced risk of dementia,
no twin studies have so far been able to show a significant associ-
ation between physical activity and cognition or dementia in a co-
twin control design controlling for genetic factors and shared
environment. Although the small number of MZ discordant pairs
may be part of the explanation, shared genes underlying physical
activity and cognition may also account for the lack of association
in the within-pair analyses.
By using an older part of theMEMTWIN data, we created a risk
score by using only self-reported educational and occupational
information (Vuoksimaa et al., 2016). Lower scores — reflecting
lower education and lower middle-age occupational status — at
a mean age of 47 years predicted cognitive status at a mean age
of 74 years with the area under the curve of 0.77 when classifying
individuals into cognitively healthy versus demented. The risk
score was also significantly associated with cognition in a sample
of 1011 individuals from younger birth cohorts (born in 1938–
1944) forming the MEMTWIN data where the mean follow-up
time was 39 years. Not only years of education were the strongest
predictor of old age cognition but also four questions about
middle-age occupational status had an independent effect on old
age cognition (Vuoksimaa et al., 2016).
Using the entire MEMTWIN data, we investigated the herit-
ability and the effect of having a cognitively impaired co-twin
on episodic memory performance in 4367 twins, including 553
MZ, 823 DZ and 19 unknown zygosity pairs (Lindgren et al.,
2019). Immediate free recall of 10-word list (single trial) had a her-
itability estimate of 0.37 with the remaining variance explained by
unique environmental effects. Looking at twin-pairs discordant for
their TELE performance (normal vs. impaired cognition), after
adjusting for age, education and sex, cognitively healthy twins
recalled more words (3.79) than their demented co-twins (3.05).
Moreover, cognitively healthy twins with demented co-twins
recalled fewer words than twins from cognitively healthy pairs
(4.23; Lindgren et al., 2019). These findings show that familial risk
of dementia is evident in poorer episodic memory performance
even in the presence of normative score in a cognitive screening
instrument. This highlights the importance of using more specific
measures of episodic memory in the early detection of cognitive
impairment. These results also suggest that immediate free recall
measure may be useful endophenotype for genetic studies of
dementia.
ADTWIN — Brain imaging of twins discordant for cognitive
status. Based on MEMTWIN data collection, we have invited
twin-pairs discordant for cognitive status to participate in the
ADTWIN study with a laboratory protocol including NP testing
and brain imaging (Scheinin et al., 2011; Virta et al., 2009). The
NP test battery included the Consortium to Establish a Registry
for Alzheimer’s Disease Neuropsychological Battery, subtests from
the Wechsler Memory Scale — Revised and the Wechsler Adult
Intelligence Scale — Revised, as well as other NP tests.
248 Jaakko Kaprio et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
Cognitive discordance was based on telephone interview and veri-
fied with the NP tests.
Brain imaging included MRI and PET with variable tracers. In
cohorts <1938, PET was used to measure β-amyloid accumulation
with 11C-Pittsburgh compound B (PiB) PET and cerebral glucose
metabolismwith 18F-Fluorodeoxyglucose (FDG) PET. Both tracers
were also used to study cognitively healthy nontwin controls. The
study using PiB included 17 cognitively discordant twin-pairs
(Scheinin et al., 2011). Those with cognitive impairment had
PiB uptake patterns typical to Alzheimer’s disease. Moreover, cog-
nitively healthy MZ co-twins had higher β-amyloid deposition,
whereas no difference in β-amyloid levels was evident in healthy
co-twins from DZ pairs compared to controls. In MZ pairs, cog-
nitively preserved co-twins showed similar PiB uptake patterns
as their cognitively impaired co-twins suggesting that genetic fac-
tors influence β-amyloid pathology (Scheinin et al., 2011).
FDG study included 16 twin-pairs and showed that cerebral
glucose metabolism was lower in the demented co-twins compared
to controls. The nondemented MZ co-twins showed reduced glu-
cose metabolism, whereas no reductions were found in the nonde-
mented DZ co-twins. The lower cerebral glucose metabolism in
nondemented MZ twins with a demented co-twin may indicate
genetic susceptibility to Alzheimer’s disease (Virta et al., 2009).
In the younger screened cohorts born in 1938–1944, PET
imaging was done in 2014–2017 and a total of 17 twin-pairs par-
ticipated in 11C-PiB PET and 11 twin-pairs participated in
11C-PRB28 PET (measuring neuroinflammation marker translo-
cator protein) imaging. These discordant twin analyses are cur-
rently ongoing.
Future Prospects — Cognitive Aging in the Oldest-Old
Given that the older FTC included all Finnish same-sex twin-pairs
born before 1958,many of these individuals have reached the age of
90 years. People who are 90 years or older are commonly referred
to as the oldest-old, and they are the fastest growing population
segment in many countries, including Finland. A big challenge
is that we know very little about cognitive and brain aging in
the oldest-old. Still, the prevalence and incidence of dementia
are highest in this age group (Brumback-Peltz et al., 2011). On
the other hand, some of the oldest-old maintain their cognitive
functioning and do have good memory even when compared to
younger age groups.
The effects of risk factors of dementiamay differ as a function of
age. In addition to low education attainment, middle-age cardio-
vascular risk factors are the most robust risk factors of dementia.
However, it is not clear whether the risk factor-dementia associa-
tions are similar across old age. For example, hypertension with
onset after 80 years of age was related to decreased risk of dementia
in the oldest-old (Corrada et al., 2017). Likewise, metabolic syn-
drome, a cluster of risk factors (hypertension, obesity, dyslipidemia
and impaired glucose metabolism) of cardiovascular disease, has
been reported to be associated with attenuated cognitive decline
in the oldest-old (van den Berg et al., 2007). Many studies in the
oldest-old have a short follow-up time, which may lead to reverse
causation when investigating the risk factors after the disease proc-
ess has started. Results based on several cohorts, including the
older FTC, suggest that higher BMI is associated with higher
dementia risk when the follow-up is over 20 years, whereas no
association is observed with a follow-up of 10–20 years and there
is an inverse association between BMI and dementia with less than
10 years of follow-up (Kivimäki et al., 2018). Genetic risk of
dementia may also differ as a function of age: having an APOE
ϵ4-allele confers risk for AD in people ≥65 years, but this effect
seems to be attenuated among the oldest-old (Corrada et al.,
2013; Valerio et al., 2014). Taken together, the middle-age factors
that predict dementia or successful cognitive aging in the oldest-
old are not well known. Survival bias in studies of ≥90 year olds
may result in having participants with high levels of resilience/cog-
nitive reserve, as indexed by protective factors such as higher gen-
eral cognitive ability and higher education or protective genetic
background.
To learn more about the risk factors for dementia in the oldest-
old, we are going to administer the telephone interview protocol to
collect cognitive data from the FTC participants who are 90 years
or older. Every year, more than 100 individuals are expected to
reach the age of 90 years. These data together with the question-
naire data from 1975 will allow investigating the longitudinal asso-
ciation with a follow-up time of 45 years or more. Moreover, we
can utilize the longitudinal FTC questionnaire data from the
1981 and 1990 questionnaires. Establishing a new database in
90-year-old twins will also make it possible to conduct more in-
depth laboratory assessment, for example, by using the
ADTWIN protocol of studying twin-pairs discordant for cognitive
functioning. Also, registry-based data in the FTC can be used to
study whether the risk factor-dementia associations are similar
across the old age.
Finnish Twin Study on Aging
The purpose of the Finnish Twin Study on Aging (FITSA) is to
study the genetic and environmental effects on the functional phe-
notypes that are relevant for the disablement process among older
women. As FITSA includes three study waves, it is a longitudinal
study embedded within the larger cohort.
The FITSA participants were recruited from the older FTC,
including 1260 female twin-pairs born in 1924–1937 (Kaprio &
Koskenvuo, 2002; Kaprio et al., 1978; Sarna et al., 1978). Of those
women who were 63–76 years old in 2000, and who had partici-
pated in the FTC surveys in 1975 and 1981, invitations to take part
in the FITSA were sent to 414 female twin-pairs living in Finland
and 103 MZ and 114 DZ twin-pairs participated. The day-long
protocol included the following assessments: biosampling, clinical
measurements, anthropometrics, body composition, physical per-
formance and sensory functions. Information about health habits
and outcomes such as functional abilities and disabilities were col-
lected in a questionnaire. Surveillance data on falls were collected
for 1 year after the laboratory examination using a calendar
method. Mortality has been followed up from the national
registers.
First follow-up measurements of FITSA were conducted after 3
years, in 2003–2004. Altogether, 419 women participated in the
follow-up study, of whom 313 participated in the laboratory mea-
surements and filled in a questionnaire, while 106 women
responded solely to the postal questionnaire. The second follow-
up round for FITSA took place in 2011–2012. Altogether, 344
(91%) of the 377 surviving participants answered a structured,
postal questionnaire, which was supplemented with telephone
interviews when needed.
There are multiple dissertations and publications about FITSA
pheno- and genotypes; for example, according to quantitative
genetic analyses, muscle strength, power and walking speed have
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a genetic effect in common (Tiainen et al., 2007). Studies about falls
have revealed that familial factors underlie the risk of falling (Pajala
et al., 2006) and that falls, as well as fear of falling, are associated
with vision and hearing acuity (Kulmala et al., 2009; Viljanen et al.,
2009, 2013). Hearing and vision are both largely accounted for by
genetic differences between individuals (Pärssinen et al., 2013,
2015, 2016, 2019; Viljanen, Era et al., 2007; Viljanen, Kaprio
et al., 2007). The FITSA study has contributed new knowledge
especially in the area of genetic and environmental effects on phe-
notypes relevant for sensory and physical functioning underlying
the disablement process in old age.
Because FITSA participants have also taken part in the FTC
surveys in years 1975 and 1981, it has been possible to do longi-
tudinal analyses in a genetically controlled sample with over
35-year follow-up from persons’middle age to old age. It has been
discovered, for example, that extraverted personality at middle
age protected from, while neuroticism increased, the risk of later
life depressive symptoms (Pakkala et al., 2010). Middle-age living
habits had no effect on depressive symptoms at old age.
According to genetic analyses, neuroticism at middle age and
depressive symptoms at old age shared an additive genetic com-
ponent, while such a common genetic component was not
observed with extraversion (Pakkala et al., 2010). We have also
reported that during the 29-year follow-up, BMI increased by
17%. Midlife BMI was a significant predictor of mobility 29 years
later. Genetic influences on BMI level and its rate of change
accounted for 37% and 25%, respectively, of the genetic
influences on mobility later in life. The corresponding environ-
mental influences on BMI level and its rate of change were
35% and 22% (Ortega-Alonso et al., 2009). FITSA data have also
been utilized in several genetic studies. For example, vision, hear-
ing and forced vital capacity have been analyzed as a part of larger
multisite consortia identifying several new associated loci/genes
(Loth et al., 2014; Vuckovic et al., 2015).
Estrogen and Sarcopenia: A Co-Twin Study With HRT
Discordant Postmenopausal Women (The SAWES Study)
Hormonal aging has notable effects on the functions of different
organs and body systems as well as on functional capacity and health
among middle-aged and older people. The most notable and well-
characterized age-induced change in hormonal systems is the
decline in sex hormone production in women during the meno-
pausal transition. Low sex hormone concentrations are among
the possible key mechanisms for sarcopenia. Sarcopenia is charac-
terized by progressive loss of skeletal muscle mass and strength with
an increased risk of adverse outcomes such as physical disability,
poor health and poor quality of life and death. The underlying bio-
logical mechanisms by which age-induced sex hormone deprivation
affects muscle mass and function are largely unknown.
The Sarcopenia — Skeletal Muscle Adaptation to
Postmenopausal Hypogonadism and Effects of Hormone
Replacement Therapy and Physical Activity in Older Women: a
Genetic and Molecular Biological Study on Estrogen-related
Pathways (SAWEs) study was launched in 2007 with the aim of
identifying the key genetic factors needed for maintaining proper
muscle mass, composition and function after menopause and to
understand their connection with estrogen status and physical
activity.
An invitation to participate the SAWEs study was sent to all
female MZ twin-pairs born in 1943–1952 (537 pairs). Of these,
114 pairs responded and 21 pairs identified themselves as being
HRT discordant, that is, one sister was a current HRT user, while
the other had never used HRT. Finally, after confirming zygosity,
15 MZ twin-pairs from those who met the inclusion criteria
formed the study group. At time of the study, enrolled participants
were 54–62 years old and their HRT discordance ranged from 2 to
16 years, with a mean (SD) duration of 6.9 (4.1) years. Of the users,
five women used estradiol preparations, six used estradiol with
progestogen preparation and four women used tibolone.
This co-twin control study found postmenopausal HRT use to
be beneficial for skeletal muscle. In particular, the greater relative
area of the thigh muscles and the lower relative fat area within the
muscle compartment among the sisters on HRT than their sisters
with no history of HRT were found (Ronkainen et al., 2009). No
significant differences between the sisters were found in maximal
voluntary isometric force (Finni et al., 2011; Ronkainen et al.,
2009). However, when the effect of the central nervous system (vol-
untary activation) was blocked using electrical stimulation to the
peripheral nerve, the force output of the plantar flexors was 32%
greater among the HRT users compared to nonusers (Finni et al.,
2011). Accordingly, the specific tension of single type I and IIa myo-
fibres was significantly greater among the HRT users than nonusers
(Qaisar et al., 2013). In fast andmore complex voluntary neuromus-
cular functions, such as the vertical countermovement jump and
maximal walking speed, the sisters on HRT performed better than
the nonusing sisters (Ronkainen et al., 2009).
Estrogens have been suggested to play a role in tendon abnor-
malities, injuries and tendon diameter. Achilles tendon thickness
and cross-sectional area did not significantly differ between
HRT using and nonusing twin sisters. However, in five physically
active pairs, the sister receiving HRT had a smaller tendon cross-
sectional area than their sisters (Finni et al., 2009). In order to
investigate the influence of long-term HRT use on bone strength
and its determinants, the peripheral computed tomography data
on tibial shaft, distal tibia and distal radius acquired from the
HRT discordant twin-pairs at the FITSA (9 pairs) and SAWEs
(15 pairs) studies were combined (Mikkola et al., 2011). The study
found no difference between HRT users and nonusers in the total
bone cross-sectional area in any of the measured bone sites but
instead showed HRT users to have higher bending strength of
the tibial shaft to be accounted from the larger cortical area and
higher cortical bone mineral density. Furthermore, the estimated
compressive strength of the distal tibia and distal radius was also
higher among theHRT users compared to their nonusing co-twins.
Several approaches have been taken in the SAWEs to investi-
gate the underlying molecular mechanisms. The investigation of
the global muscle gene expression pointed toward estrogenic
regulation of cell structure, cell-matrix interactions, energy
metabolism and utilization of nutrients pathways (Ronkainen
et al., 2010). Further studies showed that the whole-body level
differences favoring lower adiposity, higher lean mass and better
muscle performance among HRT users were also apparent in the
adiposity markers measured from blood circulation (Ahtiainen
et al., 2012) and in the pathways identified from muscle proteo-
mic study (Laakkonen et al., 2017). The focused inspection of the
intramuscular sex steroid hormones (including estradiol, testos-
terone, dihydrotestosterone and dehydroepiandrosterone)
revealed each hormone to be an independent predictor of female
muscle strength and power regardless of age, systemic estradiol
and body adiposity (Pöllänen et al., 2015).
Several microRNA-related studies have also been conducted
using samples from SAWEs. MicroRNAs are small regulatory
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RNAmolecules that function as repressors of the protein synthesis
and thereby regulate the activity of multitude of biological proc-
esses. MicroRNAs may directly affect the cells they have been pro-
duced but they can also be transported to the blood circulation and
function as endocrine regulatory elements. Within the SAWEs
study, we were first to identify estradiol-responsive microRNAs
from skeletal muscle (Olivieri et al., 2014) and later expanded these
studies to include adipose tissue (Kangas, Morsiani et al., 2017)
and circulating microRNAs (Kangas et al., 2014; Kangas,
Törmäkangas et al., 2017). The muscle-expressed estradiol-
responding microRNAs, miR-182, miR-223 and miR-142–3p,
had common targets in the insulin/IGF-1 pathway, which is known
to participate in the regulation of muscle mass (Olivieri et al.,
2014). The circulating miRs showing differential expression due
to use of HRT were associated with apoptosis, inflammation
and body metabolic pathways (Kangas et al., 2014; Kangas,
Morsiani et al., 2017). These results are in line with our previous
results indicating that the use of HRT affects muscle signaling at
transcriptome (Ronkainen et al., 2010) and proteome
(Laakkonen et al., 2017) levels, as well as white blood cell signaling
at methylome and transcriptome levels (Bahl et al., 2015).
Taken together, results from the SAWEs study indicate that
menopausal changes in circulating steroid hormones, especially
in female sex steroid estradiol, have multilevel effects on skeletal
muscle gene expression, which can be seen at the phenotype level
as increased adiposity, decreased leanmass, poorer bone properties
and reduced muscle performance. The use of HRT partially aids
maintaining better body composition and muscle function.
Biological Aging Clocks and Physical Activity and Functioning
Biological clocks, of which the most promising have been telomere
length and DNA methylation age, also known as the ‘Epigenetic
clock’, present an exciting opportunity to track and help under-
stand the human biological aging process (Horvath, 2013;
Jylhävä et al., 2017). We have investigated genetic and environ-
mental predictors of telomere length and DNA methylation age,
and how these clocks are associated with not only determinants
of older age physical functioning and LTPA at the total body level
but also in muscle tissue, which has a vital role for health and func-
tioning in old age. The aim of these studies has been to increase
knowledge about the biological mechanisms underlying the devel-
opment of age-related functional limitations and diseases.
Telomere length measurements by quantitative polymerase
chain reaction (PCR) have been performed at baseline to subsam-
ple FITSA (n= 386). For SAWEs twins, telomere length measure-
ments have also been conducted from muscle samples with the
Southern blot method (Sillanpää, Niskala et al., 2017). We collabo-
rated in a large European meta-analysis, which showed that telo-
mere length is related to lung function and lung diseases (Albrecht
et al., 2014). Following that, we showed that the associations
between telomere length and lung phenotypes are explained by
shared genetic factors underlying both phenotypes (Sillanpää,
Sipilä et al., 2017). Our analysis also revealed that telomere length
predicts a decline in physical functioning over an 11-year follow-
up (Sillanpää et al., 2016) and that telomere length is causally asso-
ciated with cognitive functions (Hägg et al., 2017). These results
indicate that telomeres are genetically regulated biomarkers that
can be used to predict the development of disability on older
age. However, as predictors of life or health span, their value is
rather low and overall, associations between telomeres and
physical functioning are weak. Telomeres measured from muscle
tissue may be more closely related to, for example, age-related loss
in muscle mass and strength than telomeres measured from white
blood cells (Sillanpää, Niskala et al., 2017).
Recently, we have expanded our biological aging research into
DNA methylation clocks. DNA methylation age estimates can be
produced from data generated by DNA methylation arrays.
Currently, about 2000 DNA samples from individuals in the twin
cohorts have been analyzed by Illumina HumanMethylation 450k
or EPIC BeadChip. In comparison to telomeres, DNAmethylation
age may be more closely associated with physical functioning phe-
notypes in older people (Sillanpää et al., 2018). Quantitative
genetic modeling in older and younger FTC revealed that the rel-
ative contribution of nonshared environmental factors was larger
among older compared with younger twin-pairs (Sillanpää et al.,
2019). We tested the hypothesis that long-term LTPA is one of
the environmental factors that affect variation in DNAm age in
older age. A co-twin control analysis with older same-sex twin-
pairs who had persistent discordance in physical activity for 32
years according to reported/interviewed physical-activity data
(TWINACTIVE) showed no differences in DNA methylation
age among active and inactive co-twins (Sillanpää et al., 2019).
The nonexistent or at most very minor associations between
LTPA and DNA methylation age were confirmed also in cross-
sectional analysis in a sample of FinnTwin16 twin-pairs.
International Activities
The FTC data, from all three cohorts (this one, FinnTwin12 and
FinnTwin16) and our research group, have been active in multiple
international consortia. There have been multiple consortia for
specific molecular genetic analyses, where the primary goal has
been to increase prediction accuracy and to achieve deeper insight
into complex trait biology by studying sample sizes as large as pos-
sible. For these, we have conducted GWAS analyses locally and
shared summary statistics for the meta-analysis. Local knowledge
of the phenotype, the circumstances of data collection and the
characteristics of the genotyping array are essential to make a suc-
cessful contribution. Likewise, we have contributed to epigenome-
wide association study meta-analyses and Mendelian
randomization meta-analyses. Only a few of the conducted analy-
ses are mentioned above.
Two more ambitious and long-term collaborations have been
the Nordic Twin study on Cancer and the CODAtwins study,
where we have been very active with leadership roles. Both
international collaborations are reviewed in the forthcoming spe-
cial issue on twin registries. We have also contributed to other
international collaborations, including IGEMS described in the
special issue. While we are open to collaboration, the current
European data protection legislation, which is very recently
updated, places constrictions on our ability to share person-level
data from the entire cohort surveys and interviews, as the limits
of what is and what is not possible are still not clear at the moment.
Please contact the first author for more information. On the other
hand, access to the data in the biobank — that is, the twins
and family members with biosamples and appropriate consents—
provides novel opportunities for researchers worldwide.
Financial support. The support for data collection and analyses of the papers
reviewed in themanuscript are mentioned in the individual articles. Support for
the preparation of this manuscript has been provided by the Academy of
Finland (grants 312073 to J. Kaprio, 314639 and 320109 to E. Vuoksimaa,
Twin Research and Human Genetics 251
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
310526 to T. Rantanen, 308698 to A. Latvala and 297908 to M. Ollikainen). N.
Lindgren was supported by the Päivikki and Sakari Sohlberg Foundation. SA
was supported by the Finnish Ministry of Education and Culture, the Juho
Vainio Foundation and the Finnish Cultural Foundation. T. Rantanen has been
supported by the European Research Council (grant number 693045) and R. J.
Rose by AA-012502.
Conflicts of interest. None.
References
Ahtiainen, M., Alén, M., Pöllänen, E., Pulkkinen, S., Ronkainen, P. H. A.,
Kujala, U. M., : : : Kovanen, V. (2012). Hormone therapy is associated with
better body composition and adipokine/glucose profiles: A study withmono-
zygotic co-twin control design. Menopause, 19, 1329–1335.
Albrecht, E., Sillanpää, E., Karrasch, S., Alves, A. C., Codd, V., Hovatta, I., &
Schulz, H. (2014). Telomere length in circulating leukocytes is associated with
lung function and disease. European Respiratory Journal, 43, 983–992.
Bahl, A., Pöllänen, E., Ismail, K., Sipilä, S., Mikkola, T. M., Berglund, E., : : :
Ollikainen, M. (2015). Hormone replacement therapy associated white
blood cell DNA methylation and gene expression are associated with
within-pair differences of body adiposity and bone mass. Twin Research
and Human Genetics, 18, 647–661.
Bollepalli, S., Korhonen, T., Kaprio, J., Ollikainen, M., & Anders, S. (2019).
EpiSmokEr: A robust classifier to determine smoking status from DNA
methylation data. bioRxiv, 487975.
Brandt, J., Spencer, M., & Folstein, M. (1988). The telephone interview for
cognitive status. Neuropsychiatry, Neuropsychology & Behavioral
Neurology, 1, 111–117.
Brazel, D. M., Jiang, Y., Hughey, J. M., Turcot, V., Zhan, X., Gong, J., : : :
Vrieze, S. (2018). Exome chip meta-analysis fine maps causal variants and
elucidates the genetic architecture of rare coding variants in smoking and
alcohol use. Biological Psychiatry, 85, 946–955.
Brumback-Peltz, C., Balasubramanian, A. B., Corrada, M.M., & Kawas, C. H.
(2011). Diagnosing dementia in the oldest-old. Maturitas, 70, 164–168.
Buchwald, J., Chenoweth,M. J. Palviainen, T., Zhu,G., Benner,C., Gordon, S.,
: : : Tyndale, R. F. (2019). Genome-wide association meta-analysis of nicotine
metabolism and cigarette consumption measures in smokers of European
descent. Manuscript submitted for publication.
Corrada, M. M., Hayden, K. M., Paganini-Hill, A., Bullain, S. S., DeMoss, J.,
Aguirre, C., : : : Kawas, C. H. (2017). Age of onset of hypertension and risk
of dementia in the oldest-old: The 90þ study. Alzheimer’s & Dementia, 13,
103–110.
Corrada, M. M., Paganini-Hill, A., Berlau, D. J., & Kawas, C. H. (2013).
Apolipoprotein E genotype, dementia, and mortality in the oldest old:
The 90þ study. Alzheimer’s & Dementia: The Journal of the Alzheimer’s
Association, 9, 12–18.
Erzurumluoglu, A. M., Liu, M., Jackson, V. E., Barnes, D. R., Datta, G.,
Melbourne, C., : : : Howson, J. M. M. (2019). A meta-analysis of up to
622,409 individuals identifies 40 novel smoking behaviour associated genetic
loci. Molecular Psychiatry. Advance online publication. https://doi.org/10.
1038/s41380-018-0313-0
Evangelou, E., Warren, H. R., Mosen-Ansorena, D., Mifsud, B., Pazoki, R.,
Gao, H., : : : Caulfield, M. J. (2018). Genetic analysis of over 1 million peo-
ple identifies 535 new loci associated with blood pressure traits. Nature
Genetics, 50, 1412–1425.
Evins, E., Korhonen, T., Kinnunen, T. H., & Kaprio, J. (2017). Prospective
association between tobacco smoking and death by suicide: A competing
risks hazard analysis in a large twin cohort with 35-year follow up.
Psychological Medicine, 47, 2143–2154.
Finni, T., Kovanen, V., Ronkainen, P. H., Pöllänen, E., Bashford, G. R.,
Kaprio, J., : : : Sipilä, S. (2009). Combination of hormone replacement
therapy and high physical activity is associated with differences in
Achilles tendon size in monozygotic female twin pairs. Journal of Applied
Physiology (1985), 106, 1332–1337.
Finni, T., Noorkoiv, M., Pöllänen, E., Ronkainen, P. H., Alén, M., Kaprio, J.,
: : : Sipilä, S. (2011). Muscle function in monozygotic female twin pairs dis-
cordant for hormone replacement therapy. Muscle Nerve, 44, 769–775.
Gatz, M., Reynolds, C. A., John, R., Johansson, B., Mortimer, J. A., &
Pedersen, N. L. (2002). Telephone screening to identify potential dementia
cases in a population-based sample of older adults. International
Psychogeriatrics, 14, 273–289.
Gupta, R., Qaiser, B., He, L., Hiekkalinna, T. S., Zheutlin, A. B., Therman, S.,
: : : Loukola, A. (2017). Neuregulin signaling pathway in smoking behavior.
Translational Psychiatry, 7, e1212.
Gupta, R., vanDongen, J., Fu, Y., Abdellaoui, A., Tyndale, R. F., Velagapudi, V.,
: : : Ollikainen, M. (2019). Epigenome-wide association study of serum coti-
nine in current smokers reveals novel genetically driven loci. Clinical
Epigenetics, 11, 1.
Hägg, S., Zhan, Y., Karlsson, R., Gerritsen, L., Ploner, A., van der Lee, S. J.,
: : : Pedersen, N. L. (2017). Short telomere length is associated with
impaired cognitive performance in European ancestry cohorts.
Translational Psychiatry, 7, e1100.
Hancock,D.B.,Guo,Y., Reginsson,G.W.,Gaddis,N.C., Lutz, S.M., Sherva,R.,
: : : Johnson, E. O. (2018). Genome-wide association study across European
and African American ancestries identifies a SNP in DNMT3B contributing
to nicotine dependence. Molecular Psychiatry, 23, 1911–1919.
He, L., Pitkäniemi, J., Heikkilä, K., Chou, Y. L.,Madden, P. A., Korhonen, T.,
: : : Loukola, A. (2016). Genome-wide time-to-event analysis on smoking
progression stages in a family-based study. Brain and Behavior, 6, e00462.
Hoffmann, T. J., Ehret, G. B., Nandakumar, P., Ranatunga, D., Schaefer, C.,
Kwok, P. Y., : : : Risch, N. (2017). Genome-wide association analyses using
electronic health records identify new loci influencing blood pressure varia-
tion. Nature Genetics, 49, 54–64.
Horvath, S. (2013). DNA methylation age of human tissues and cell types.
Genome Biology, 14, R115.
Huang, Y., Ollikainen, M., Sipilä, P., Mustelin, L., Wang, X., Su, S., : : :
Wang, X. (2018). Genetic and environmental effects on gene expression sig-
natures of blood pressure: A transcriptome-wide twin study. Hypertension,
71, 457–464.
Hublin, C., Lehtovirta,M., Partinen,M., Koskenvuo,M., & Kaprio, J. (2018).
Changes in sleep quality with age— A 36-year follow-up study of Finnish
working-aged adults. Journal of Sleep Research, 27, e12623.
Iso-Markku, P., Waller, K., Kujala, U. M., & Kaprio, J. (2015). Physical activ-
ity and dementia: Long-term follow-up study of adult twins. Annals of
Medicine, 47, 81–87.
Iso-Markku, P.,Waller, K., Vuoksimaa, E., Heikkilä, K., Rinne, J., Kaprio, J.,
& Kujala, U.M. (2016). Midlife physical activity and cognition later in life: A
prospective twin study. Journal of Alzheimers Disease, 54, 1303–1317.
Iso-Markku, P., Waller, K., Vuoksimaa, E., Vähä-Ypyä, H., Lindgren, N.,
Heikkilä, K., : : : Kujala, U.M. (2018). Objectively measured physical activ-
ity profile and cognition in Finnish elderly twins. Alzheimers & Dementia
(NY), 4, 263–271.
Jylhävä, J., Pedersen, N. L., & Hägg, S. (2017). Biological age predictors.
EBioMedicine, 21, 29–36.
Kangas, R., Morsiani, C., Pizza, G., Lanzarini, C., Aukee, P., Kaprio, J., : : :
Capri, M. (2017). Menopause and adipose tissue: miR-19a-3p is sensitive to
hormonal replacement. Oncotarget, 9, 2279–2294.
Kangas, R., Pöllänen, E., Rippo, M. R., Lanzarini, C., Prattichizzo, F.,
Niskala, P., : : : Kovanen, V. (2014). Circulating miR-21, miR-146a and
Fas ligand respond to postmenopausal hormone replacement therapy —
A study with monozygotic twin pairs. Mechanisms of Ageing and
Development, 15, 1–8.
Kangas, R., Törmäkangas, T., Fey, V., Pursiheimo, J., Miinalainen, I., Alen, M.,
: : : Laakkonen, E. K. (2017). Aging and serum exomiR content in women—
Effects of estrogenic hormone replacement therapy. Scientific Reports, 14, 42702.
Kaprio, J. (2006). Twin studies in Finland 2006. Twin Research and Human
Genetics, 9, 772–777.
Kaprio, J. (2013). The Finnish Twin Cohort Study: An update. Twin Research
and Human Genetics, 16, 157–162.
Kaprio, J., & Koskenvuo, M. (2002). Genetic and environmental factors
in complex diseases: The older Finnish Twin Cohort. Twin Research, 5,
358–365.
Kaprio, J., Sarna, S., Koskenvuo, M., & Rantasalo, I. (1978) The Finnish twin
registry: Formation and compilation, questionnaire study, zygosity
252 Jaakko Kaprio et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
determination procedures, and research program. Progress in Clinical and
Biological Research, 24, 179–184.
Karvinen, S.,Waller, K., Silvennoinen,M., Koch, L. G., Britton, S. L., Kaprio, J.,
: : : Kujala, U. M. (2015). Physical activity in adulthood: Genes and mortality.
Scientific Reports, 5, Article no. 18259.
Kato, N., Loh, M., Takeuchi, F., Verweij, N., Wang, X., Zhang, W., : : :
Chambers, J. C. (2015). Trans-ancestry genome-wide association study
identifies 12 genetic loci influencing blood pressure and implicates a role
for DNA methylation. Nature Genetics, 47, 1282–1293.
Kivimäki, M., Luukkonen, R., Batty, G. D., Nyberg, S. T., Alfredsson, L.,
Fransson, E. I., : : : Jokela, M. (2018). Body mass index and risk of demen-
tia: Analysis of individual-level data from 1.3 million individuals. Alzheimers
& Dementia, 14, 601–609.
Korhonen, T., Broms, U., Varjonen, J., Romanov, K., Koskenvuo, M.,
Kinnunen, T., & Kaprio, J. (2007). Smoking behaviour as a predictor for
depression among Finnish men and women— A prospective study of adult
twins. Psychological Medicine, 37, 705–715.
Korhonen, T., Koivumaa-Honkanen, H., Varjonen, J., Broms, U.,
Koskenvuo, M., & Kaprio, J. (2011). Cigarette smoking and dimensions
of depressive symptoms: Longitudinal analysis among Finnish male and
female twins. Nicotine & Tobacco Research, 13, 261–272.
Korhonen, T., Ranjit, A., Tuulio-Henriksson, A., & Kaprio, J. (2017).
Smoking status as a predictor of antidepressant medication use. Journal of
Affective Disorders, 207, 221–227.
Kujala, U. M., Hautasaari, P., Vähä-Ypyä, H., Waller, K., Lindgren, N.,
Iso-Markku, P., : : : Sievänen, H. (2019). Chronic diseases and objectively
measured physical activity among aged individuals—A cross-sectional twin
cohort study. Annals of Medicine, 51, 78–87.
Kujala, U. M., Mäkinen, V.-P., Heinonen, I., Soininen, P., Kangas, A. J.,
Leskinen, T., : : : Ala-Korpela, M. (2013). Long-term leisure-time physical
activity and serum metabolome. Circulation, 127, 340–348.
Kulmala, J., Viljanen, A., Sipilä, S., Pajala, S., Pärssinen, O., Kauppinen, M.,
: : : Rantanen, T. (2009). Poor vision accompaniedwith other sensory impair-
ments as a predictor of falls in older women. Age and Ageing, 38, 162–167.
Laakkonen, E. K., Soliymani, R., Karvinen, S., Rintala, P., Kaprio, J.,
Kujala, U., : : : Lalowski,M. (2017). Estrogenic regulation of skeletal muscle
proteome: A study of premenopausal women and postmenopausal MZ cot-
wins discordant for hormonal therapy. Aging Cell, 16, 1276–1287.
Lerman, C., Tyndale, R., Patterson, F., Wileyto, E. P., Shields, P. G., Pinto,
A., & Benowitz, N. (2006) Nicotine metabolite ratio predicts efficacy of
transdermal nicotine for smoking cessation. Clinical Pharmacology &
Therapeutics, 79, 600–608.
Leskinen, T., &Kujala, U.M. (2015). Health-related findings among twin pairs
discordant for leisure-time physical activity for 32 years: The TWINACTIVE
study synopsis. Twin Research and Human Genetics, 18, 266–272.
Leskinen, T., Rinnankoski-Tuikka, R., Rintala, M., Seppänen-Laakso, T.,
Pöllänen, E., Alen, M., : : : Kujala, U. M. (2010). Differences in muscle
and adipose tissue gene expression and cardio-metabolic risk factors in
the members of physical activity discordant twin pairs. Plos One, 5, e12609.
Leskinen, T., Sipilä, S., Alen, M., Cheng, S., Pietiläinen, K. H., Usenius, J.-P.,
: : : Kujala, U. M. (2009). Leisure time physical activity and high-risk fat: A
longitudinal population-based twin study. International Journal of Obesity,
33, 1211–1218.
Leskinen, T., Sipilä, S., Kaprio, J., Kainulainen, H., Alen, M., & Kujala, U.M.
(2013). Physically active lifestyle, muscle properties and glucose homeostasis
in middle-aged and older twins. Age, 35, 1917–1926.
Leskinen, T., Waller, K., Mutikainen, S., Aaltonen, S., Ronkainen, P. H. A.,
Alen, M., : : : Kujala, U. M. (2009). Effects of 30-year leisure time physical
activity discordance in twin pairs on health (TWINACTIVE study); aims,
design and results for physical fitness. Twin Research and Human
Genetics, 12, 108–117.
Lindgren, N., Kaprio, J., Rinne, J. O., & Vuoksimaa, E. (2019). Immediate
verbal recall and familial dementia risk: Population-based study of over
4000 twins. Journal of Neurology, Neurosurgery & Psychiatry, 90, 90–97.
Liu,M., Jiang,Y.,Wedow,R.,Li,Y.,Brazel,D.M.,Chen,F., : : : Vrieze, S. (2019).
Association studies of up to 1.2 million individuals yield new insights into the
genetic etiology of tobacco and alcohol use. Nature Genetics, 51, 237–244.
Loth, D., Artigas, M., Gharib, S., Wain, L. V., Franceschini, N., Koch, B., : : :
London, S. J. (2014). Genome-wide association analysis identifies six new
loci associated with forced vital capacity. Nature Genetics, 46, 669–677.
Loukola, A., Buchwald, J., Gupta, R., Palviainen, T., Hällfors, J., Tikkanen, E.,
& Kaprio, J. (2015). Genome-wide association study of a biomarker of nico-
tine metabolism. PLOS Genetics, 11, e1005498.
Mikkola, T. M., Heinonen, A., Kovanen, V., Cheng, S., Kujala, U. M.,
Suominen,H., : : : Sipilä, S. (2011). Influence of long-term postmenopausal
hormone-replacement therapy on estimated structural bone strength: A
study in discordant monozygotic twins. Journal of Bone and Mineral
Research, 226, 546–552.
Mucci, L. A., Hjelmborg, J. B., Harris, J. R., Czene, K., Havelick, D. J.,
Scheike, T., : : : Nordic Twin Study of Cancer (NorTwinCan)
Collaboration. (2016). Familial risk and heritability of cancer among twins
in Nordic countries. JAMA, 315, 68–76.
Olivieri, F., Ahtiainen, M., Lazzarini, R., Pöllänen, E., Capri, M., Lorenzi, M.,
& Procopio, A.D. (2014). Hormone replacement therapy enhances IGF-1 sig-
naling in skeletal muscle by diminishingmiR-182 andmiR-223 expressions: A
study on postmenopausal monozygotic twin pairs. Aging Cell, 13, 850–61
Ortega-Alonso, A., Sipilä, S., Kujala, U. M., Kaprio, J., & Rantanen, T.
(2009). Genetic influences on adult body mass index followed over 29 years
and their effects on late-life mobility: A study of twin sisters. Journal of
Epidemiology & Community Health, 63, 651–658.
Pajala, S., Era, P., Koskenvuo, M., Kaprio, J., Viljanen, A., & Rantanen, T.
(2006). Genetic factors and susceptibility to falls in older women. Journal of
the American Geriatrics Society, 54, 613–618.
Pakkala, I., Read, S., Kaprio, J., Koskenvuo,M., Kauppinen,M., & Rantanen,
T. (2010). Genetic contribution to the relationship between personality and
depressive symptoms among older women. Psychological Medicine, 40,
1357–1366.
Pärssinen, O., Kauppinen, M., Halekoh, U., Kaprio, J., & Rantanen, T.
(2019). Heredity of interocular similarities in components of refraction: A
population-based twin study among 66- to 79-year-old female twins. Acta
Ophthalmologica. Advance online publication. doi: 10.1111/aos.14033
Pärssinen, O., Kauppinen, M., Kaprio, J., Koskenvuo, M., & Rantanen, T.
(2013). Heritability of refractive astigmatism: A population-based twin study
among 63- to 75-year-old female twins. Investigative Ophthalmology &
Visual Science, 54, 6063–6067.
Pärssinen, O., Kauppinen, M., Kaprio, J., Koskenvuo, M., & Rantanen, T.
(2015). Heritability of anterior chamber depth and axial length: A popula-
tion-based twin study among 66 to 79-year old female twins. Acta
Ophthalmologica, 93, e177–178.
Pärssinen, O., Kauppinen, M., Kaprio, J., & Rantanen, T. (2016).
Anisometropia of ocular refractive and biometric measures among 66- to
79-year-old female twins. Acta Ophthalmologica, 94, 768–774.
Partanen, J., Bruun, K., & Markkanen, T. (1966). Inheritance of drinking
behavior, Study No. 14. Helsinki, Finland: The Finnish Foundation for
Alcohol Studies.
Piirtola, M., Kaprio, J., Kujala, U. M., Heikkilä, K., Koskenvuo, M.,
Svedberg, P., : : : Ropponen, A. (2016). Association between education
and future leisure-time physical inactivity: A study of Finnish twins over
a 35-year follow-up. BMC Public Health, 16, 720.
Piirtola, M., Kaprio, J., Silventoinen, K., Svedberg, P., Korhonen, T., &
Ropponen, A. (2017). Association between long-term smoking and lei-
sure-time physical inactivity: A cohort study among Finnish twins with a
35-year follow-up. International Journal of Public Health, 62, 819–829.
Piirtola, M., Kaprio, J., Waller, K., Heikkilä, K., Koskenvuo, M., Svedberg, P.,
: : : Ropponen, A. (2017). Leisure-time physical inactivity and association
with body mass index: A Finnish Twin Study with a 35-year follow-up.
International Journal of Epidemiology, 46, 116–127.
Pöllänen, E., Kangas, R., Horttanainen, M., Niskala, P., Kaprio, J.,
Butler-Browne, G., : : : Kovanen, V. (2015). Intramuscular sex steroid hor-
mone are associated with skeletal muscle strength and power in women with
different hormonal status. Aging Cell, 14, 236–248.
Qaisar, R., Renaud, G.,Hedstrom, Y., Pöllänen, E., Ronkainen, P., Kaprio, J.,
: : : Larsson, L. (2013). Hormone replacement therapy improves contractile
function and myonuclear organization of single muscle fibres from
Twin Research and Human Genetics 253
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
postmenopausal monozygotic female twin pairs. Journal of Physiology, 591,
2333–2344.
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for
research in the general population. Applied Psychological Measures, 1,
385–401.
Ronkainen, P. H. A., Kovanen, V., Alén, M., Pöllänen, E., Palonen, E. M.,
Ankarberg-Lindgren, C., : : : Sipilä, S. (2009). Postmenopausal hormone
replacement therapy modifies skeletal muscle composition and function:
A study with monozygotic twin pairs. Journal of Applied Physiology, 107,
25–33.
Ronkainen, P. H. A., Pöllänen, E., Alén, M., Pitkänen, R., Puolakka, J.,
Kujala, U. M., : : : Kovanen, V. (2010). Global gene expression profiles
in skeletal muscle of monozygotic female twins discordant for hormone
replacement therapy. Aging Cell, 9, 1098–1110.
Sarna, S., Kaprio, J., Sistonen, P., & Koskenvuo, M. (1978). Diagnosis of twin
zygosity by mailed questionnaire. Human Heredity, 28, 241–254.
Scheinin, N.M., Aalto, S., Kaprio, J., Koskenvuo,M., Räihä, I., Rokka, J., : : :
Rinne, J. O. (2011). Early detection of Alzheimer disease: ¹¹C-PiB PET in
twins discordant for cognitive impairment. Neurology, 77, 453–460.
Sillanpää, E., Kaprio, J., Laakkonen, E. K., Vaara, E., Rantanen, T., Kovanen, V.,
: : : Ollikainen,M. (2018). Biological clocks and physical functioning inmono-
zygotic female twins. BMC Geriatrics, 18, 83.
Sillanpää, E., Niskala, P., Laakkonen, E. K., Ponsot, E., Alén, M., Kaprio, J., : : :
Sipilä, S. (2017). Leukocyte and skeletal muscle telomere length and body com-
position in monozygotic twin pairs discordant for long-term hormone replace-
ment therapy. Twin Research and Human Genetics, 20, 119–131.
Sillanpää, E., Ollikainen,M., Kaprio, J., Wang, X., Leskinen, T., Kujala, U.M.,
& Törmäkangas, T. (2019). Leisure-time physical activity and DNAmethyla-
tion age— A twin study. Clinical Epigenetics, 11, 12.
Sillanpää, E., Sipilä, S., Törmäkangas, T., Kaprio, J., & Rantanen, T. (2017).
Genetic and environmental effects on telomere length and lung function: A
twin study. The Journals of Gerontology. Series A, Biological sciences and
Medical Sciences, 73, 1561–1568.
Sillanpää, E., Törmäkangas, T., Rantanen, T., Kaprio, J., & Sipilä, S. (2016).
Does telomere length predict decline in physical functioning in older twin
sisters during 11-year follow-up? Age (Dordrecht), 38, 1–10.
Sipilä, P., Rose, R. J., & Kaprio, J. (2015). Drinking and mortality: Long-term
follow-up of drinking-discordant twin pairs. Addiction, 111, 245–254.
Tiainen, K., Pajala, S., Sipilä, S., Kaprio, J., Koskenvuo, M., Alén, M., : : :
Rantanen, T. (2007). Genetic effects in common on maximal walking speed
and muscle performance in older women. Scandinavian Journal of Medicine
and Science in Sports, 17, 274–280.
Tuomela, J., Kaprio, J., Sipilä, P. N., Silventoinen, K.,Wang, X., Ollikainen,M.,
&Piirtola,M. (in press). Accuracy of self-reported anthropometricmeasures—
Findings from the Finnish Twin Study. Obesity Research and Clinical Practice.
Valerio, D., Raventos, H., Schmeidler, J., Beeri, M. S., Villalobos, L. M.,
Bolanos-Palmieri, P., : : : Silverman, J. M. (2014). Association of apolipo-
protein E-e4 and dementia declines with age. The American Journal of
Geriatric Psychiatry, 22, 957–960.
van den Berg, E., Biessels, G. J., de Craen, A. J., Gussekloo, J., &Westendorp,
R. G. (2007). The metabolic syndrome is associated with decelerated cogni-
tive decline in the oldest old. Neurology, 69, 979–985.
Viljanen, A., Era, P., Kaprio, J., Pyykkö, I., Koskenvuo, M., & Rantanen, T.
(2007). Genetic and environmental influences on hearing in older women.
The Journals of Gerontology, Series A: Biological Sciences and Medical
Sciences, 62A, 447–452.
Viljanen, A., Kaprio, J., Pyykkö, I., Sorri, M., Kauppinen, M., Koskenvuo,
M., & Rantanen, T. (2007). Genetic and environmental influences on hear-
ing at different frequencies separately for the better and worse hearing ear in
older women. International Journal of Audiology, 46, 772–779.
Viljanen, A., Kaprio, J., Pyykkö, I., Sorri, M., Pajala, S., Kauppinen, M., : : :
Rantanen, T. (2009). Hearing as a predictor of falls and postural balance in
older female twins. The Journals of Gerontology, Series A: Biological Sciences
and Medical Sciences, 64A, 312–317.
Viljanen, A., Kulmala, J., Rantakokko, M., Koskenvuo, M., Kaprio, J., &
Rantanen, T. (2013). Accumulation of sensory difficulties predicts fear of
falling in older women. Journal of Aging and Health, 25, 776–791.
Virta, J. J., Aalto, S., Järvenpää, T., Karrasch, M., Kaprio, J., Koskenvuo, M.,
: : : Rinne, J. O. (2009). Voxel-based analysis of cerebral glucosemetabolism
in mono- and dizygotic twins discordant for Alzheimer disease. Journal of
Neurology, Neurosurgery & Psychiatry, 80, 259–266.
Virta, J. J., Heikkila, K., Perola, M., Koskenvuo, M., Raiha, I., Rinne, J. O., &
Kaprio, J. (2013). Midlife cardiovascular risk factors and late cognitive
impairment. European Journal of Epidemiology, 28, 405–416.
Virtanen, S., Kaprio, J., Viken, R., Rose, R., & Latvala, A. (2018). Birth cohort
effects on the quantity and heritability of alcohol consumption in adulthood:
A Finnish longitudinal twin study. Addiction, 114, 836–846.
Vuckovic,D.,Dawson, S., Scheffer,D.I, Rantanen, T.,Morgan,A.,Di Stazio,M,
: : : Girotto, G. (2015). Genome-wide association analysis on normal hearing
function identifies PCDH20 and SLC28A3 as candidates for hearing function
and loss. Human Molecular Genetics, 24, 5655–5664.
Vuoksimaa, E., Rinne, J. O., Lindgren, N., Heikkilä, K., Koskenvuo, M., &
Kaprio, J. (2016). Middle age self-report risk score predicts cognitive func-
tioning and dementia in 20–40 years. Alzheimers and Dementia
(Amsterdam), 4, 118–125.
Wain, L. V., Vaez, A., Jansen, R., Joehanes, R., van der Most, P. J.,
Erzurumluoglu, A. M., : : : Ehret, G. B. (2017). Novel blood pressure locus
and gene discovery using genome-wide association study and expression
data sets from blood and the kidney. Hypertension, 70, e4–e19.
Waller, K., Kaprio, J., Korhonen, T., Tuulio-Henriksson, A., & Kujala, U.M.
(2016). Persistent leisure-time physical activity in adulthood and use of anti-
depressants: A follow-up study among twins. Journal of Affective Disorders,
200, 172–177.
Waller, K., Kaprio, J., & Kujala, U.M. (2008). Associations between long-term
physical activity, waist circumference and weight gain: A 30-year longi-
tudinal twin study. International Journal of Obesity, 32, 353–361.
Waller, K., Kaprio, J., & Kujala, U. M. (2014). Dyspnea and all-cause mortal-
ity: 28-year follow-up study among adult twins.Medicine & Science in Sports
& Exercise, 46, 1538–1545.
Waller, K., Kaprio, J., Lehtovirta, M., Silventoinen, K., Koskenvuo, M., &
Kujala, U. M. (2010). Leisure-time physical activity and type 2 diabetes dur-
ing a 28-year follow-up in twins. Diabetologia, 53, 2531–2537.
Waller, K., Kujala, U. M., Kaprio, J., Koskenvuo, M., & Rantanen, T. (2010).
Effect of physical activity on health in twins: A 30-year longitudinal study.
Medicine & Science in Sports & Exercise, 42, 658–664.
Waller, K., Kujala, U. M., Rantanen, T., Kauppinen, M., Silventoinen, K.,
Koskenvuo, M., & Kaprio, J. (2010). Physical activity, morbidity and mor-
tality in twins: A 24-year prospective follow-up. European Journal of
Epidemiology, 25, 731–739.
Waller, K., Vähä-Ypyä, H., Lindgren, N., Kaprio, J., Sievänen, H., & Kujala,
U.M. (2018). Self-reported fitness and objectively measured physical activity
profile among older adults: A twin study. The Journals of Gerontology, Series
A, gly263. Advance online publication.
Waller, K., Vähä-Ypyä, H., Törmäkangas, T., Hautasaari, P., Lindgren, N.,
Iso-Markku, P., & Kujala, U. M. (2018). Long-term leisure-time physical
activity and other health habits as predictors of objectively monitored
late-life physical activity— A 40-year twin study. Scientific Reports, 8, 9400.
Walters, R. K., Polimanti, R., Johnson, E. C., McClintick, J. N., Adams,M. J.,
Adkins, A. E., : : : Agrawal, A. (2018). Transancestral GWAS of alcohol
dependence reveals common genetic underpinnings with psychiatric disor-
ders. Nature Neuroscience, 21, 1656–1669.
Wang, X., Falkner, B., Zhu, H., Shi, H., Su, S., Xu, X., : : : Snieder, H. (2013).
A genome-wide methylation study on essential hypertension in young
African American males. PLoS One, 8, e53938.
Warren, H. R., Evangelou, E., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B.,
: : : Wain, L. V. (2017). Genome-wide association analysis identifies novel
blood pressure loci and offers biological insights into cardiovascular risk.
Nature Genetics, 49, 403–415.
254 Jaakko Kaprio et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2019.54
Downloaded from https://www.cambridge.org/core. Helsinki University Library, on 31 Oct 2019 at 11:25:50, subject to the Cambridge Core terms of use, available at
